PT Diagnos Laboratorium Utama Tbk

Jakarta Stock Exchange DGNS.JK

PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 743.56 K

PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities is USD 743.56 K for the year ending December 31, 2023, a 69.44% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 438.84 K, a -86.03% change year over year.
  • PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 3.14 M, a 1,629.89% change year over year.
  • PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -205.32 K, a -115.93% change year over year.
  • PT Diagnos Laboratorium Utama Tbk Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 1.29 M.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
Jakarta Stock Exchange: DGNS.JK

PT Diagnos Laboratorium Utama Tbk

CEO Engineer Mesha Rizal Sini
IPO Date Jan. 15, 2021
Location Indonesia
Headquarters Gedung Graha Anam Lantai 2
Employees 91
Sector Health Care
Industries
Description

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing, preimplantation genetic testing for aneuploidy services, and preimplantation genetic testing for monogenic diseases services. It also offers homecare health services for health checks that can be done at home; corporate health services; and covid-19 check-up services, as well as health care activities managed by the government and the private sector, such as pharmacy warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other health care services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Similar companies

DMMX.JK

PT Digital Mediatama Maxima Tbk

USD 0.01

-5.93%

HEAL.JK

PT Medikaloka Hermina Tbk

USD 0.08

-1.41%

BMHS.JK

PT Bundamedik Tbk

USD 0.02

1.64%

IRRA.JK

PT Itama Ranoraya Tbk

USD 0.02

1.32%

PRDA.JK

PT Prodia Widyahusada Tbk

USD 0.16

0.08%

StockViz Staff

February 1, 2025

Any question? Send us an email